HIGHLIGHTS
- who: Tiziana Filardi from the Centre for Genomic Regulation (CRG), Spain Lancaster University, United Kingdom have published the research work: Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases, in the Journal: (JOURNAL)
SUMMARY
The concern for neurodegeneration, a worldwide expanding set of diseases, stimulated the research on risk factors related to the lifestyle of the population, leading to interesting findings on the association between dysmetabolism and brain impairment. Indeed, insulin works as prosurvival neurotrophic factor with its receptor widespread in cognitive areas as hippocampus and in dopaminergic system (Haas et_al, 2016; Fiory . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.